Peptide Industry beginner
Peptide Industry Partnerships
Strategic partnerships and collaborations in the peptide therapeutics industry.
By Encyclopeptide Editorial | 1 min read
partnerships collaboration deals licensing
Overview
Strategic partnerships between pharma, biotech, and CDMOs drive peptide drug development and commercialization.
Partnership Types
- Licensing deals: Acquiring rights to peptide platforms
- Co-development: Sharing development costs and risks
- CDMO agreements: Manufacturing partnerships
- Academic collaborations: Translating research to clinic
Notable Deals
- Novo Nordisk oral peptide technology acquisitions
- Eli Lilly incretin franchise partnerships
- Bicycle Therapeutics pharma collaborations
- Protagonist Janssen co-development
Trends
Increasing deal values and more creative deal structures reflect the growing value of peptide platforms.
References
- Source: ENCP Peptide Database
- Category: Peptide Industry
Test Your Knowledge
Reinforce what you learned about Peptide Industry Partnerships with interactive quizzes on Wikipept.
Take a Quiz on Wikipept